A significant decrease in the viability of ER+ breast cancer cell lines (MCF-7 and T-47D) was observed after treatment with the three GQD clusters, with the o-GQD cluster treatment showing the most significant decrease. This evidence concerns the gene ESR1 and breast carcinoma.